FIGURE
Figure 5
- ID
- ZDB-FIG-221031-157
- Publication
- He et al., 2022 - Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 5
Ab-dmLNP/siRNARelA attenuates endothelial inflammatory activation after down-regulation of NF-κB P65 (RelA), which is as effective as lipofectamine. ( |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Pharmaceutics